Positron Biogenics Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.50 Cr
- Revenue Growth 60.00%
- Profit Growth -16.81%
- Ebitda 11.62%
- Net Worth 409.48%
- Total Assets 1378.23%
About Positron Biogenics
Positron Biogenics Private Limited (PBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 May 2020 (Four years and nine months 6 days old ). Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹26.50 Cr.
Bhavya Shukla and Preety Shukla serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290HR2020PTC086287
- Company No.
086287
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Positron Biogenics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavya Shukla  | Director | 20-May-2020 | Current |
| Preety Shukla | Director | 20-May-2020 | Current |
Financial Performance of Positron Biogenics.
Positron Biogenics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60% increase. The company also saw a substantial fall in profitability, with a 16.81% decrease in profit. The company's net worth Soared by an impressive increase of 409.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Positron Biogenics?
In 2023, Positron Biogenics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Panacea Diagnostic Lab And Health Services Private LimitedBhavya Shukla is a mutual person
Charges (Loans)
₹26.50 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 26.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2022 | State Bank Of India | ₹26.50 Cr | Open |
How Many Employees Work at Positron Biogenics?
Positron Biogenics has a workforce of 20 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Positron Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Positron Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.